{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T10:51:27Z","timestamp":1789210287125,"version":"build-2803163510"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Prostaglandins &amp; Other Lipid Mediators"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.prostaglandins.2015.04.009","type":"journal-article","created":{"date-parts":[[2015,5,8]],"date-time":"2015-05-08T12:22:07Z","timestamp":1431087727000},"page":"28-33","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Role of Lipocalin-type prostaglandin D2 synthase (L-PGDS) and its metabolite, prostaglandin D2, in preterm birth"],"prefix":"10.1016","volume":"118-119","author":[{"given":"Sunil","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Palaia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher E.","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8292-5159","authenticated-orcid":false,"given":"Louis","family":"Ragolia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5 Pt 1","key":"10.1016\/j.prostaglandins.2015.04.009_bib0115","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1097\/01.AOG.0000158124.96300.c7","article-title":"Trends in preterm birth and perinatal mortality among singletons: United States, 1989 through 2000","volume":"105","author":"Ananth","year":"2005","journal-title":"Obstet Gynecol"},{"issue":"9832","key":"10.1016\/j.prostaglandins.2015.04.009_bib0120","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1016\/S0140-6736(12)60560-1","article-title":"Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000","volume":"379","author":"Liu","year":"2012","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.prostaglandins.2015.04.009_bib0125","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2147\/vhrm.2006.2.1.19","article-title":"Noninvasive assessment of preclinical atherosclerosis","volume":"2","author":"Lane","year":"2006","journal-title":"Vasc Health Risk Manag"},{"issue":"9344","key":"10.1016\/j.prostaglandins.2015.04.009_bib0130","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/S0140-6736(02)11476-0","article-title":"Preterm delivery","volume":"360","author":"Slattery","year":"2002","journal-title":"Lancet"},{"issue":"9832","key":"10.1016\/j.prostaglandins.2015.04.009_bib0135","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1016\/S0140-6736(12)60820-4","article-title":"National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications","volume":"379","author":"Blencowe","year":"2012","journal-title":"Lancet"},{"issue":"5 Suppl.","key":"10.1016\/j.prostaglandins.2015.04.009_bib0140","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1016\/j.ajog.2005.02.015","article-title":"Biochemical markers for the prediction of preterm birth","volume":"192","author":"Goldenberg","year":"2005","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.prostaglandins.2015.04.009_bib0145","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1067\/mob.2002.121727","article-title":"The Preterm Prediction Study: the value of serum alkaline phosphatase, alpha-fetoprotein, plasma corticotropin-releasing hormone, and other serum markers for the prediction of spontaneous preterm birth","volume":"186","author":"Moawad","year":"2002","journal-title":"Am J Obstet Gynecol"},{"issue":"5 Pt 1","key":"10.1016\/j.prostaglandins.2015.04.009_bib0150","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/0029-7844(96)00035-X","article-title":"The preterm prediction study: fetal fibronectin testing and spontaneous preterm birth. NICHD Maternal Fetal Medicine Units Network","volume":"87","author":"Goldenberg","year":"1996","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.prostaglandins.2015.04.009_bib0155","first-page":"225","article-title":"Vaginal fetal fibronectin levels and spontaneous preterm birth in symptomatic women","volume":"97","author":"Lu","year":"2001","journal-title":"Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.prostaglandins.2015.04.009_bib0160","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1073\/pnas.1323977111","article-title":"Farnesoid X receptor (FXR) gene deficiency impairs urine concentration in mice","volume":"111","author":"Zhang","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.prostaglandins.2015.04.009_bib0165","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.plefa.2003.04.002","article-title":"Prostaglandin synthases: recent developments and a novel hypothesis","volume":"70","author":"Helliwell","year":"2004","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"issue":"1","key":"10.1016\/j.prostaglandins.2015.04.009_bib0170","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1341-8076.2004.00158.x","article-title":"Changes of lipocalin-type prostaglandin D synthase level during pregnancy","volume":"30","author":"Shiki","year":"2004","journal-title":"J Obstet Gynaecol Res"},{"issue":"10","key":"10.1016\/j.prostaglandins.2015.04.009_bib0175","doi-asserted-by":"crossref","first-page":"6209","DOI":"10.1021\/cr200010h","article-title":"Prostanoid receptors","volume":"111","author":"Hirata","year":"2011","journal-title":"Chem Rev"},{"issue":"6","key":"10.1016\/j.prostaglandins.2015.04.009_bib0180","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1194\/jlr.M800619-JLR200","article-title":"Activation of farnesoid X receptor prevents atherosclerotic lesion formation in LDLR\u2212\/\u2212 and apoE\u2212\/\u2212 mice","volume":"50","author":"Hartman","year":"2009","journal-title":"J Lipid Res"},{"issue":"7499","key":"10.1016\/j.prostaglandins.2015.04.009_bib0185","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/nature13135","article-title":"FXR is a molecular target for the effects of vertical sleeve gastrectomy","volume":"509","author":"Ryan","year":"2014","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.prostaglandins.2015.04.009_bib0190","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1194\/jlr.M027094","article-title":"Dual actions of fibroblast growth factor 19 on lipid metabolism","volume":"54","author":"Wu","year":"2013","journal-title":"J Lipid Res"},{"issue":"8","key":"10.1016\/j.prostaglandins.2015.04.009_bib0195","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1161\/ATVBAHA.109.197897","article-title":"A role of the bile salt receptor FXR in atherosclerosis","volume":"30","author":"Hageman","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"10.1016\/j.prostaglandins.2015.04.009_bib0200","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/01.smj.0000208120.73327.db","article-title":"Clinical utility of bile acid sequestrants in the treatment of dyslipidemia: a scientific review","volume":"99","author":"Insull","year":"2006","journal-title":"South Med J"},{"issue":"12","key":"10.1016\/j.prostaglandins.2015.04.009_bib0205","doi-asserted-by":"crossref","first-page":"7623","DOI":"10.1074\/jbc.M808593200","article-title":"Biochemical: functional, and pharmacological characterization of AT-56, an orally active and selective inhibitor of lipocalin-type prostaglandin D synthase","volume":"284","author":"Irikura","year":"2009","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.prostaglandins.2015.04.009_bib0210","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1152\/physrev.00010.2008","article-title":"Role of bile acids and bile acid receptors in metabolic regulation","volume":"89","author":"Lefebvre","year":"2009","journal-title":"Physiol Rev"},{"issue":"2","key":"10.1016\/j.prostaglandins.2015.04.009_bib0215","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1210\/jc.2005-1982","article-title":"Gestational age-dependent up-regulation of prostaglandin D synthase (PGDS) and production of PGDS-derived antiinflammatory prostaglandins in human placenta","volume":"91","author":"Helliwell","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"7347","key":"10.1016\/j.prostaglandins.2015.04.009_bib0220","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nature10146","article-title":"Progress and challenges in translating the biology of atherosclerosis","volume":"473","author":"Libby","year":"2011","journal-title":"Nature"}],"container-title":["Prostaglandins &amp; Other Lipid Mediators"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098882315000519?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098882315000519?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,22]],"date-time":"2018-09-22T15:26:04Z","timestamp":1537629964000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098882315000519"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":22,"alternative-id":["S1098882315000519"],"URL":"https:\/\/doi.org\/10.1016\/j.prostaglandins.2015.04.009","relation":{},"ISSN":["1098-8823"],"issn-type":[{"value":"1098-8823","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of Lipocalin-type prostaglandin D2 synthase (L-PGDS) and its metabolite, prostaglandin D2, in preterm birth","name":"articletitle","label":"Article Title"},{"value":"Prostaglandins & Other Lipid Mediators","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prostaglandins.2015.04.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}